Why Are Heavyweights Like Apple And Microsoft Partnered With Spherix Incorporated?
Devon Shire • 15 Comments
Devon Shire • 15 Comments
Spherix And Its Rockstar Announcement: A Big Deal For A Small Company
Adam Gill • 23 Comments
Adam Gill • 23 Comments
Thu, May 26, 12:45 PM
Wed, May 25, 12:50 PM
Wed, May 25, 9:20 AM
Tue, May 24, 2:54 PM
- Under a second licensing deal with IP risk-management services firm RPX (RPXC), Spherix (SPEX +79.1%) "receives a cash payment and return of all of the Series H preferred stock of Spherix presently held by RPX, representing the entire class of Series H shares outstanding." In return, Spherix is granting RPX a patent portfolio license RPX can sub-license to its clients.
- With the company having a market cap of less than $6M going into today, Spherix has blasted off on the news.
Tue, May 24, 12:50 PM
Tue, May 24, 9:14 AM
Tue, Mar. 15, 2:42 PM
- Spherix (SPEX -2.7%) has expanded its agreement with IP enforcement/monetization fund Equitable to cover the monetization of certain Nortel and North South patent assets. Spherix previously struck a deal with Equitable to monetize its CompuFill patent portfolio.
- Spherix CEO Anthony Hayes: "By commencing their work and legal initiatives before May 1, 2016, Equitable will be the beneficiary of a measured yet robust incentive arrangement. Of the 10 new suits that we expect to file, at least seven must apply to the Nortel patents, while two must be against licensees that have public market capitalizations in excess of $1 billion."
- Last week: Spherix up strongly after shareholder letter
Thu, Mar. 10, 12:48 PM
Mon, Mar. 7, 12:15 PM
- "Our goal is to drive long-term shareholder value through partnerships that will initiate litigation across numerous technology sectors, including: routers, switching, networking, optical, and internet service," says Spherix (SPEX +21.4%) CEO Anthony Hayes in a letter, trying to drum up shareholder support. "Multiple litigations, against multiple licensees, in multiple technology fields will help to optimize potential revenue generation."
- He asserts Spherix can now pursue its strategy, after having recently satisfied preferred stock payment obligations and seen the termination of security interests on its assets. "Prior to the end of 2015, we did not have the right to leverage our portfolio in such a manner."
- Hayes adds licensing talks continue with IP risk-management services firm RPX, and that his company hopes to reach a deal. "By agreement, these discussions can continue until May 23rd of this year. If an agreement is not reached by May 23rd, then the agreed "stay" on litigation expires and the number of potential licensees to our portfolio increases significantly."
- The letter comes after Spherix carried out a 1:19 reverse split on Friday.
Mon, Feb. 29, 10:05 AM| Mon, Feb. 29, 10:05 AM | 1 Comment
Dec. 2, 2015, 9:52 AM
- Spherix (NASDAQ:SPEX) is raising $4M by selling 20M Class A units consisting of one share, a warrant (exercisable for 6 months) to buy one share at a price equal to the unit offering price, and a warrant (exercisable for 5 years) to buy 0.8 shares at a price equal to 125% of the unit offering price.
- Spherix is also issuing Class B units to those investors whose purchase of A units would lead them to own more than a 4.99% stake in the company following the offering. Each B unit consists of one Class K convertible preferred share, which in turn is convertible into common stock at the A unit offering price.
- Shares have plunged below $0.19; the 52-week low is $0.17. Ahead of today's announcement, Spherix tried to drum up investor enthusiasm by issuing a PR detailing potential licensing opportunities.
Oct. 19, 2015, 10:06 AM
- Spherix (NASDAQ:SPEX) and Chinese IT/telecom equipment Huawei have settled all litigation, with the latter obtaining a patent license from the former. At the joint request of both companies, the USPTO has terminated inter partes reviews involving two Spherix patents.
- Spherix jumped in August on news it has signed an MOU with Huawei that "favorably resolves" Spherix's suit. Shares still -38% YTD.
Aug. 24, 2015, 2:28 PM
- Spherix (NASDAQ:SPEX) has signed an MOU with Huawei that "favorably resolves" an infringement suit against the Chinese tech giant. Management expects "all documents necessary to resolve this matter will be executed in the next 30 days." Terms are undisclosed.
- Shares have soared in afternoon trading, after initially seeing more modest gains. They're still down 62% YTD.
Jul. 16, 2015, 9:53 AM
- Spherix (NASDAQ:SPEX) has reached agreements with institutional investors to sell 5.72M units consisting of one share and a warrant to buy 1.23 shares. The warrants will carry a $0.43 exercise price, be exercisable six months and one day after the closing of the offering, and expire 5.5 years after the offering's close.
- Gross proceeds are expected to total $1.5M, excluding any warrant exercises - that implies each unit will be sold for ~$0.26. Spherix had $2.9M in cash at the end of Q1, and currently has 28.6M shares outstanding.
Jul. 2, 2015, 9:44 AM
- Spherix (SPEX -1%) states the Eastern Virginia federal court handling its infringement suit against Verizon issued a Markman Order "interpreting certain key claims" in Verizon's favor for the sole patent at issue in the case. As a result, Verizon's motion for summary judgment was granted.
- CEO Anthony Hayes: "We are disappointed by the judge's decision in this case. At this stage, we are reviewing the Court's decision, analyzing the appealable issues and considering all our options." The company notes it's asserting 20 other patents in different cases, and that the infringement claims asserted in a second suit against Verizon weren't affected.
Mar. 31, 2015, 1:17 PM
- Spherix (NASDAQ:SPEX) filed its 2014 10-K after the close yesterday afternoon.
- Shares are down 12% over the last two days. Yesterday morning, Spherix announced the trial date for its suit against Verizon had been pushed back from May 18 to August 10.
- Spherix soared 11 days ago after receiving a favorable claim construction order for its suits against VTech and Uniden.
Spherix, Inc. operates as an intellectual property company that owns patented and unpatented intellectual property. Its principal activities include the acquisition and development of patents through internal or external research and development. In addition, the company intends to acquire... More
Industry: Medical Laboratories & Research
Country: United States
Other News & PR